ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 268665 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 268665; 2) Community: the network communities that were significantly associated with the response to NSC 268665; 3) Molecule: the relationships between components within communities and NSC 268665; 4) MDR: the compounds that were significantly associated with the NSC 268665.

NSC Compound Enrichment Correlation
NSC 710416 Null 0.0133012546828912 0.141802
NSC 712411 Null 0.0133012546828912 0.18613285
NSC 72942 DL-Noformicin 0.0133012546828912 0.10514078
NSC 734872 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.0133012546828912 0.32752831
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0133012546828912 0.28036025
NSC 745962 5-iodo-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0133012546828912 0.1737427
NSC 749505 3,4-diphenylisoxazolo[3,4-d]pyridazin-7(6H)-one 0.0133012546828912 0.14048683
NSC 76519 Inosine, 6-thio-, 2',3',5'-tris(4-methoxybenzoate) 0.0133012546828912 -0.10482456
NSC 80141 Null 0.0133012546828912 0.26638153
NSC 136037 AT 116, benzylamine salt 0.0133012546828914 -0.027449146
Total:39  Current:10    [First] [Prev] [Next] [Last]